Organon OGN
NYSE OGN
$13.73 +0.03 (+0.18%)
As of: Oct 1, 2026 · 3:59 PM EDT

Organon (OGN) Non Operating Interest Expenses (2021 - 2026)

Updated

Organon's Non Operating Interest Expenses was $108 million in Q2 2026, down 17.6% from $131 million a year earlier and down 2.7% from the prior quarter.

Analysis

Organon (OGN) Non Operating Interest Expenses (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Organon's Non Operating Interest Expenses was $468 million through Jun 30, 2026, down 8.8% year-over-year; for FY2025, it came in at $504 million, down 3.1% from FY2024.

  • Non Operating Interest Expenses shows a four-year compound annual growth rate of 18.2% (FY2021 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $520 million in FY2024 (-1.3%), $527 million in FY2023 (+24.9%), $422 million in FY2022 (+63.6%) and $258 million in FY2021.
  • Quarterly Non Operating Interest Expenses has moved between $97 million (Q1 2022) and $134 million (Q3 2023) over five years.
  • Compared with a year earlier, Non Operating Interest Expenses has declined for three straight quarters, with an average decline of 5.5% over the last eight quarters.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q2 2022 (growth of 58.1%); the worst was Q2 2026 (a decline of 17.6%).
  • Per Business Quant data, OGN's Non Operating Interest Expenses in the three quarters before Q2 2026 was $111 million (Q1 2026), $121 million (Q4 2025) and $128 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Organon 3.60 Bn 106.37 Mn 847.00 Mn 108.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108.00 Mn
Mar 31, 2026 111.00 Mn
Dec 31, 2025 121.00 Mn
Sep 30, 2025 128.00 Mn
Jun 30, 2025 131.00 Mn
Mar 31, 2025 124.00 Mn
Dec 31, 2024 132.00 Mn
Sep 30, 2024 126.00 Mn
Jun 30, 2024 131.00 Mn
Mar 31, 2024 131.00 Mn
Dec 31, 2023 129.00 Mn
Sep 30, 2023 134.00 Mn
Jun 30, 2023 132.00 Mn
Mar 31, 2023 132.00 Mn
Dec 31, 2022 119.00 Mn
Sep 30, 2022 108.00 Mn
Jun 30, 2022 98.00 Mn
Mar 31, 2022 97.00 Mn
Dec 31, 2021 98.00 Mn
Sep 30, 2021 98.00 Mn
API Access

Organon Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=OGN&period=max&api_key=YOUR_API_KEY